<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39273613</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Sex Differences in Expression of Pro-Inflammatory Markers and miRNAs in a Mouse Model of CVB3 Myocarditis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9666</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25179666</ELocationID><Abstract><AbstractText>Myocarditis is an inflammatory disease that may lead to dilated cardiomyopathy. Viral infection of the myocardium triggers immune responses, which involve, among others, macrophage infiltration, oxidative stress, expression of pro-inflammatory cytokines, and microRNAs (miRNAs). The cardioprotective role of estrogen in myocarditis is well documented; however, sex differences in the miRNA expression in chronic myocarditis are still poorly understood, and studying them further was the aim of the present study. Male and female ABY/SnJ mice were infected with CVB3. Twenty-eight days later, cardiac tissue from both infected and control mice was used for real-time PCR and Western blot analysis. NFκB, IL-6, iNOS, TNF-α, IL-1β, MCP-1, c-fos, and osteopontin (OPN) were used to examine the inflammatory state in the heart. Furthermore, the expression of several inflammation- and remodeling-related miRNAs was analyzed. NFκB, IL-6, TNF-α, IL-1β, iNOS, and MCP-1 were significantly upregulated in male mice with CVB3-induced chronic myocarditis, whereas OPN mRNA expression was increased only in females. Further analysis revealed downregulation of some anti-inflammatory miRNA in male hearts (let7a), with upregulation in female hearts (let7b). In addition, dysregulation of remodeling-related miRNAs (miR27b and mir199a) in a sex-dependent manner was observed. Taken together, the results of the present study suggest a sex-specific expression of pro-inflammatory markers as well as inflammation- and remodeling-related miRNAs, with a higher pro-inflammatory response in male CVB3 myocarditis mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Estepa</LastName><ForeName>Misael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiology, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niehues</LastName><ForeName>Maximilian H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute for Gender in Medicine, Center for Cardiovascular Research, Charité University Hospital, 10115 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakhrusheva</LastName><ForeName>Olesya</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Tübingen, 72076 Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haritonow</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Geriatrics and Medical Gerontology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladilov</LastName><ForeName>Yury</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9836-8801</Identifier><AffiliationInfo><Affiliation>Heart Center Brandenburg, Department of Cardiovascular Surgery, Brandenburg Medical School, 16321 Bernau bei Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcena</LastName><ForeName>Maria Luisa</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-1391-9262</Identifier><AffiliationInfo><Affiliation>Department of Urology, University Hospital Tübingen, 72076 Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regitz-Zagrosek</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Gender in Medicine, Center for Cardiovascular Research, Charité University Hospital, 10115 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Zürich, University of Zürich, 8091 Zürich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVB3-induced chronic myocarditis</Keyword><Keyword MajorTopicYN="N">cardiac inflammation</Keyword><Keyword MajorTopicYN="N">estrogen</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39273613</ArticleId><ArticleId IdType="pmc">PMC11395254</ArticleId><ArticleId IdType="doi">10.3390/ijms25179666</ArticleId><ArticleId IdType="pii">ijms25179666</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olejniczak M., Schwartz M., Webber E., Shaffer A., Perry T.E. Viral Myocarditis-Incidence, Diagnosis and Management. J. Cardiothorac. Vasc. Anesth. 2020;34:1591–1601. doi: 10.1053/j.jvca.2019.12.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.12.052</ArticleId><ArticleId IdType="pubmed">32127272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670–680. doi: 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Rose N.R. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods. 2007;41:118–122. doi: 10.1016/j.ymeth.2006.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.07.009</ArticleId><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft L., Erdenesukh T., Sauter M., Tschope C., Klingel K. Blocking the IL-1beta signalling pathway prevents chronic viral myocarditis and cardiac remodeling. Basic. Res. Cardiol. 2019;114:11. doi: 10.1007/s00395-019-0719-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-019-0719-0</ArticleId><ArticleId IdType="pubmed">30673858</ArticleId></ArticleIdList></Reference><Reference><Citation>Afanasyeva M., Georgakopoulos D., Belardi D.F., Bedja D., Fairweather D., Wang Y., Kaya Z., Gabrielson K.L., Rodriguez E.R., Caturegli P., et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. USA. 2005;102:180–185. doi: 10.1073/pnas.0408241102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408241102</ArticleId><ArticleId IdType="pmc">PMC544075</ArticleId><ArticleId IdType="pubmed">15611472</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinzierl A.O., Szalay G., Wolburg H., Sauter M., Rammensee H.G., Kandolf R., Stevanovic S., Klingel K. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4−/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J. Virol. 2008;82:8149–8160. doi: 10.1128/JVI.00047-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00047-08</ArticleId><ArticleId IdType="pmc">PMC2519575</ArticleId><ArticleId IdType="pubmed">18550677</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G., Luo H., Qiu Y., Yang D., McManus B. Myocarditis. Circ. Res. 2016;118:496–514. doi: 10.1161/CIRCRESAHA.115.306573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306573</ArticleId><ArticleId IdType="pubmed">26846643</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronado M.J., Bruno K.A., Blauwet L.A., Tschope C., Cunningham M.W., Pankuweit S., van Linthout S., Jeon E.S., McNamara D.M., Krejci J., et al. Elevated Sera sST2 Is Associated With Heart Failure in Men &lt;/= 50 Years Old With Myocarditis. J. Am. Heart Assoc. 2019;8:e008968. doi: 10.1161/JAHA.118.008968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.008968</ArticleId><ArticleId IdType="pmc">PMC6497352</ArticleId><ArticleId IdType="pubmed">30638108</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorga A., Cunningham C.M., Moazeni S., Ruffenach G., Umar S., Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol. Sex. Differ. 2017;8:33. doi: 10.1186/s13293-017-0152-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-017-0152-8</ArticleId><ArticleId IdType="pmc">PMC5655818</ArticleId><ArticleId IdType="pubmed">29065927</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisancho-Kiss S., Nyland J.F., Davis S.E., Frisancho J.A., Barrett M.A., Rose N.R., Fairweather D. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res. 2006;1126:139–147. doi: 10.1016/j.brainres.2006.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.08.003</ArticleId><ArticleId IdType="pubmed">16949558</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Xu W., Guo Q., Jiang Z., Wang P., Yue Y., Xiong S. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 2009;105:353–364. doi: 10.1161/CIRCRESAHA.109.195230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.195230</ArticleId><ArticleId IdType="pubmed">19608981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N., Reddy J. An overview of the immune mechanisms of viral myocarditis. Rev. Med. Virol. 2020;30:1–14. doi: 10.1002/rmv.2131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2131</ArticleId><ArticleId IdType="pubmed">32720461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294:63–69. doi: 10.1016/j.cellimm.2015.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2015.01.018</ArticleId><ArticleId IdType="pmc">PMC4380804</ArticleId><ArticleId IdType="pubmed">25682174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R.S., Goyal N. Estrogens as regulator of hematopoietic stem cell, immune cells and bone biology. Life Sci. 2021;269:119091. doi: 10.1016/j.lfs.2021.119091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119091</ArticleId><ArticleId IdType="pubmed">33476629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Han B. Dysregulated CD4+ T Cells and microRNAs in Myocarditis. Front. Immunol. 2020;11:539. doi: 10.3389/fimmu.2020.00539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00539</ArticleId><ArticleId IdType="pmc">PMC7109299</ArticleId><ArticleId IdType="pubmed">32269577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S.S., Jin J.P., Wang J.Q., Zhang Z.G., Freedman J.H., Zheng Y., Cai L. miRNAS in cardiovascular diseases: Potential biomarkers, therapeutic targets and challenges. Acta Pharmacol. Sin. 2018;39:1073–1084. doi: 10.1038/aps.2018.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2018.30</ArticleId><ArticleId IdType="pmc">PMC6289363</ArticleId><ArticleId IdType="pubmed">29877320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihakova D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008;99:95–114. doi: 10.1016/S0065-2776(08)00604-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(08)00604-4</ArticleId><ArticleId IdType="pubmed">19117533</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen P., van den Akker F., Deddens J.C., Sluijter J.P. Heart Failure in Chronic Myocarditis: A Role for microRNAs? Curr. Genom. 2015;16:88–94. doi: 10.2174/1389202916999150120153344.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202916999150120153344</ArticleId><ArticleId IdType="pmc">PMC4467309</ArticleId><ArticleId IdType="pubmed">26085807</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cai S., Ding X., Lu C., Wu R., Wu H., Shang Y., Pang M. MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1. Am. J. Physiol. Heart Circ. Physiol. 2021;320:H1348–H1360. doi: 10.1152/ajpheart.00431.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00431.2020</ArticleId><ArticleId IdType="pubmed">33416455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang M., Li X., Tang Z., Wang X., Zhong M., Suo Q., Zhang Y., Lv K. Silencing MicroRNA-155 Attenuates Cardiac Injury and Dysfunction in Viral Myocarditis via Promotion of M2 Phenotype Polarization of Macrophages. Sci. Rep. 2016;6:22613. doi: 10.1038/srep22613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22613</ArticleId><ArticleId IdType="pmc">PMC4773853</ArticleId><ArticleId IdType="pubmed">26931072</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.M., Chen M.G., Chen D.W., Wu W.F., Liu Y.L., Lin F.H. The effect of microRNA-21 on myocardial fibrosis in mice with chronic viral myocarditis. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46:450–457. doi: 10.3760/cma.j.issn.0253-3758.2018.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0253-3758.2018.06.008</ArticleId><ArticleId IdType="pubmed">29925181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandolf R., Hofschneider P.H. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA. 1985;82:4818–4822. doi: 10.1073/pnas.82.14.4818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.14.4818</ArticleId><ArticleId IdType="pmc">PMC390996</ArticleId><ArticleId IdType="pubmed">2410905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakel S., Kuckelkorn U., Szalay G., Plotz M., Textoris-Taube K., Opitz E., Klingel K., Stevanovic S., Kandolf R., Kotsch K., et al. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am. J. Pathol. 2009;175:510–518. doi: 10.2353/ajpath.2009.090033.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090033</ArticleId><ArticleId IdType="pmc">PMC2716952</ArticleId><ArticleId IdType="pubmed">19590042</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcena M.L., Jeuthe S., Niehues M.H., Pozdniakova S., Haritonow N., Kuhl A.A., Messroghli D.R., Regitz-Zagrosek V. Sex-Specific Differences of the Inflammatory State in Experimental Autoimmune Myocarditis. Front. Immunol. 2021;12:686384. doi: 10.3389/fimmu.2021.686384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686384</ArticleId><ArticleId IdType="pmc">PMC8195335</ArticleId><ArticleId IdType="pubmed">34122450</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowski B., Kleibert M., Majka M., Wojciechowska M. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells. 2022;11:1553. doi: 10.3390/cells11091553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11091553</ArticleId><ArticleId IdType="pmc">PMC9105930</ArticleId><ArticleId IdType="pubmed">35563860</ArticleId></ArticleIdList></Reference><Reference><Citation>Asrih M., Mach F., Nencioni A., Dallegri F., Quercioli A., Montecucco F. Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. Mediators Inflamm. 2013;2013:367245. doi: 10.1155/2013/367245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/367245</ArticleId><ArticleId IdType="pmc">PMC3556856</ArticleId><ArticleId IdType="pubmed">23365487</ArticleId></ArticleIdList></Reference><Reference><Citation>Opavsky M.A., Martino T., Rabinovitch M., Penninger J., Richardson C., Petric M., Trinidad C., Butcher L., Chan J., Liu P.P. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Investig. 2002;109:1561–1569. doi: 10.1172/JCI0213971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI0213971</ArticleId><ArticleId IdType="pmc">PMC151008</ArticleId><ArticleId IdType="pubmed">12070303</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Gao L., Fu X., Meng Q., Lu Z. Scutellaria baicalensis Inhibits Coxsackievirus B3-Induced Myocarditis Via AKT and p38 Pathways. J. Microbiol. Biotechnol. 2019;29:1230–1239. doi: 10.4014/jmb.1904.04050.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1904.04050</ArticleId><ArticleId IdType="pubmed">31370111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kublickiene K., Luksha L. Gender and the endothelium. Pharmacol. Rep. 2008;60:49–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">18276985</ArticleId></ArticleIdList></Reference><Reference><Citation>Piro M., Della Bona R., Abbate A., Biasucci L.M., Crea F. Sex-related differences in myocardial remodeling. J. Am. Coll. Cardiol. 2010;55:1057–1065. doi: 10.1016/j.jacc.2009.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.09.065</ArticleId><ArticleId IdType="pubmed">20223363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinceti E., Shults C.L., Rao Y.S., Pak T.R. Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats. PLoS ONE. 2016;11:e0160276. doi: 10.1371/journal.pone.0160276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0160276</ArticleId><ArticleId IdType="pmc">PMC4972350</ArticleId><ArticleId IdType="pubmed">27487271</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao M.H., Feng X., Zhang Y.W., Lou X.Y., Cheng Y., Zhou H.H. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int. J. Mol. Sci. 2013;14:23086–23102. doi: 10.3390/ijms141123086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141123086</ArticleId><ArticleId IdType="pmc">PMC3856107</ArticleId><ArticleId IdType="pubmed">24284400</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Jun M., Ahn M.R., Kim O.Y. Involvement of miR-Let7A in inflammatory response and cell survival/apoptosis regulated by resveratrol in THP-1 macrophage. Nutr. Res. Pract. 2016;10:377–384. doi: 10.4162/nrp.2016.10.4.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.4162/nrp.2016.10.4.377</ArticleId><ArticleId IdType="pmc">PMC4958639</ArticleId><ArticleId IdType="pubmed">27478543</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng G.G., Wang W.H., Dai Y., Wang S.J., Chu Y.X., Li J. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS ONE. 2013;8:e56709. doi: 10.1371/journal.pone.0056709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056709</ArticleId><ArticleId IdType="pmc">PMC3577724</ArticleId><ArticleId IdType="pubmed">23437218</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye I.S., Coomes S.M., Pelly V.S., Czieso S., Papayannopoulos V., Tolmachova T., Seabra M.C., Wilson M.S. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity. 2014;41:89–103. doi: 10.1016/j.immuni.2014.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.05.019</ArticleId><ArticleId IdType="pmc">PMC4104030</ArticleId><ArticleId IdType="pubmed">25035954</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Wu J.S., Yan Y., Li J., Ni T., Shao W., Mei J.H., Xiong W.Z., Wu H. MiR-199a modulates autophagy and inflammation in rats with cerebral infarction via regulating mTOR expression. Eur. Rev. Med. Pharmacol. Sci. 2020;24:6338–6345. doi: 10.26355/eurrev_202006_21532.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202006_21532</ArticleId><ArticleId IdType="pubmed">32572931</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Shao Y., Guo H.C., Zhi Y., Qiao B., Ma K., Du J., Lai Y.Q., Li Y. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc. Res. 2022;118:2139–2151. doi: 10.1093/cvr/cvab248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab248</ArticleId><ArticleId IdType="pmc">PMC9302889</ArticleId><ArticleId IdType="pubmed">34358309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Lu Z., Fu X., Ma S., Lu X. MicroRNA 27b promotes cardiac fibrosis by targeting the FBW7/Snail pathway. Aging. 2019;11:11865–11879. doi: 10.18632/aging.102465.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102465</ArticleId><ArticleId IdType="pmc">PMC6949061</ArticleId><ArticleId IdType="pubmed">31881012</ArticleId></ArticleIdList></Reference><Reference><Citation>Asensio-Lopez M.C., Sassi Y., Soler F., Fernandez Del Palacio M.J., Pascual-Figal D., Lax A. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI. Sci. Rep. 2021;11:3915. doi: 10.1038/s41598-021-82745-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82745-9</ArticleId><ArticleId IdType="pmc">PMC7887255</ArticleId><ArticleId IdType="pubmed">33594087</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed B.G., Babayev S.N., Chen L.X., Carr B.R., Word R.A., Jimenez P.T. Estrogen-regulated miRNA-27b is altered by bisphenol A in human endometrial stromal cells. Reproduction. 2018;156:559–567. doi: 10.1530/REP-18-0041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-18-0041</ArticleId><ArticleId IdType="pmc">PMC6215928</ArticleId><ArticleId IdType="pubmed">30328349</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran S., Schwartz A., Lundberg G. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: Risks, benefits, and current guidelines for use. Ther. Adv. Endocrinol. Metab. 2021;12:20420188211013917. doi: 10.1177/20420188211013917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20420188211013917</ArticleId><ArticleId IdType="pmc">PMC8111523</ArticleId><ArticleId IdType="pubmed">34104397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Huang C. Coxsackieviruses B3 infection of myocardial microvascular endothelial cells activates fractalkine via the ERK1/2 signaling pathway. Mol. Med. Rep. 2017;16:7548–7552. doi: 10.3892/mmr.2017.7536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7536</ArticleId><ArticleId IdType="pmc">PMC5865889</ArticleId><ArticleId IdType="pubmed">28944873</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Yanagawa B., Zhang J., Luo Z., Zhang M., Esfandiarei M., Carthy C., Wilson J.E., Yang D., McManus B.M. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 2002;76:3365–3373. doi: 10.1128/JVI.76.7.3365-3373.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.7.3365-3373.2002</ArticleId><ArticleId IdType="pmc">PMC136021</ArticleId><ArticleId IdType="pubmed">11884562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Xie W., Zhang L., Li D., Yu H., Xiong J., Peng J., Qiu J., Sheng H., He X., et al. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway. J. Virol. 2018;92:10–1128. doi: 10.1128/JVI.01060-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01060-18</ArticleId><ArticleId IdType="pmc">PMC6258932</ArticleId><ArticleId IdType="pubmed">30258014</ArticleId></ArticleIdList></Reference><Reference><Citation>Dama A., Baggio C., Boscaro C., Albiero M., Cignarella A. Estrogen Receptor Functions and Pathways at the Vascular Immune Interface. Int. J. Mol. Sci. 2021;22:4254. doi: 10.3390/ijms22084254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084254</ArticleId><ArticleId IdType="pmc">PMC8073008</ArticleId><ArticleId IdType="pubmed">33923905</ArticleId></ArticleIdList></Reference><Reference><Citation>Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 2002;80:239–256. doi: 10.1016/S0960-0760(01)00189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-0760(01)00189-3</ArticleId><ArticleId IdType="pubmed">11897507</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll J.X., Fry A.C., Mosier E.M. Sex-based differences in resting MAPK, androgen, and glucocorticoid receptor phosphorylation in human skeletal muscle. Steroids. 2019;141:23–29. doi: 10.1016/j.steroids.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.steroids.2018.11.004</ArticleId><ArticleId IdType="pubmed">30414425</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell A.L., Chung B.Y.T., Creighton C.E., Kalisch B.E., Bailey C.D.C., MacLusky N.J. Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid beta in SH-SY5Y cells and primary cortical neurons. Brain Res. 2018;1686:83–93. doi: 10.1016/j.brainres.2018.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.02.023</ArticleId><ArticleId IdType="pubmed">29477545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell A.L., MacLusky N.J. The testosterone metabolite 3alpha-androstanediol inhibits oxidative stress-induced ERK phosphorylation and neurotoxicity in SH-SY5Y cells through an MKP3/DUSP6-dependent mechanism. Neurosci. Lett. 2019;696:60–66. doi: 10.1016/j.neulet.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.12.012</ArticleId><ArticleId IdType="pubmed">30552945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., He B., Goldstein S., Ge J., Wang Z., Ruiz G. The expression and significance of proto-oncogene c-fos in viral myocarditis. Virol. J. 2010;7:285. doi: 10.1186/1743-422X-7-285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-285</ArticleId><ArticleId IdType="pmc">PMC2976746</ArticleId><ArticleId IdType="pubmed">20979618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray N., Kuwahara M., Takada Y., Maruyama K., Kawaguchi T., Tsubone H., Ishikawa H., Matsuo K. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 2006;18:671–677. doi: 10.1093/intimm/dxl004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxl004</ArticleId><ArticleId IdType="pubmed">16569682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Liao Y., Chen Z., Gao X., Dong J. Expression of IL-1beta and TNF-alpha in MCMV myocarditis and its role. J. Huazhong Univ. Sci. Technol. Med. Sci. 2005;25:254–256, 259. doi: 10.1007/BF02828134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02828134</ArticleId><ArticleId IdType="pubmed">16201263</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Kandolf R. Osteopontin: A biomarker to predict the outcome of inflammatory heart disease. Semin. Thromb. Hemost. 2010;36:195–202. doi: 10.1055/s-0030-1251504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1251504</ArticleId><ArticleId IdType="pubmed">20414835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D., Andreoletti L., Shen L., Copin M.C., Desmidt A., Wattre P. Coxsackievirus B3-induced chronic myocarditis in mouse: Use of whole blood culture to study the activation of TNF alpha-producing cells. Microbiol. Immunol. 1996;40:837–845. doi: 10.1111/j.1348-0421.1996.tb01149.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1996.tb01149.x</ArticleId><ArticleId IdType="pubmed">8985939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Yu J., Sun H., Zhao Y., Wang J., Zhang J., Meng B. Effects of ubiquitin-proteasome inhibitor on the expression levels of TNF-alpha and TGF-beta1 in mice with viral myocarditis. Exp. Ther. Med. 2019;18:2799–2804. doi: 10.3892/etm.2019.7895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7895</ArticleId><ArticleId IdType="pmc">PMC6755415</ArticleId><ArticleId IdType="pubmed">31555373</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Wang C., Mao Y., Cui J., Wang X., Dang J., Wang S. The expression of STAT3 inhibited the NF-KappaB signalling pathway and reduced inflammatory responses in mice with viral myocarditis. Int. Immunopharmacol. 2021;95:107534. doi: 10.1016/j.intimp.2021.107534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107534</ArticleId><ArticleId IdType="pubmed">33752081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianconi V., Sahebkar A., Atkin S.L., Pirro M. The regulation and importance of monocyte chemoattractant protein-1. Curr. Opin. Hematol. 2018;25:44–51. doi: 10.1097/MOH.0000000000000389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000389</ArticleId><ArticleId IdType="pubmed">28914666</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuse K., Kodama M., Hanawa H., Okura Y., Ito M., Shiono T., Maruyama S., Hirono S., Kato K., Watanabe K., et al. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin. Exp. Immunol. 2001;124:346–352. doi: 10.1046/j.1365-2249.2001.01510.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2001.01510.x</ArticleId><ArticleId IdType="pmc">PMC1906075</ArticleId><ArticleId IdType="pubmed">11472393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihakova D., Sharma R.B., Fairweather D., Afanasyeva M., Rose N.R. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 2004;102:175–193. doi: 10.1385/1-59259-805-6:175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-805-6:175</ArticleId><ArticleId IdType="pubmed">15286386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam C.S.P., Arnott C., Beale A.L., Chandramouli C., Hilfiker-Kleiner D., Kaye D.M., Ky B., Santema B.T., Sliwa K., Voors A.A. Sex differences in heart failure. Eur. Heart J. 2019;40:3859–3868. doi: 10.1093/eurheartj/ehz835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz835</ArticleId><ArticleId IdType="pubmed">31800034</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz-Zagrosek V., Kararigas G. Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol. Rev. 2017;97:1–37. doi: 10.1152/physrev.00021.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00021.2015</ArticleId><ArticleId IdType="pubmed">27807199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo A., Gibson K., Cisneros J., Richards T.J., Yang Y., Becerril C., Yousem S., Herrera I., Ruiz V., Selman M., et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2005;2:e251. doi: 10.1371/journal.pmed.0020251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020251</ArticleId><ArticleId IdType="pmc">PMC1198037</ArticleId><ArticleId IdType="pubmed">16128620</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalay G., Sauter M., Haberland M., Zuegel U., Steinmeyer A., Kandolf R., Klingel K. Osteopontin: A fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009;104:851–859. doi: 10.1161/CIRCRESAHA.109.193805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.193805</ArticleId><ArticleId IdType="pubmed">19246678</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz Mohamed I., Gadeau A.P., Hasan A., Abdulrahman N., Mraiche F. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis. Cells. 2019;8:1558. doi: 10.3390/cells8121558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121558</ArticleId><ArticleId IdType="pmc">PMC6952988</ArticleId><ArticleId IdType="pubmed">31816901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ti D., Hao H., Tong C., Liu J., Dong L., Zheng J., Zhao Y., Liu H., Fu X., Han W. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J. Transl. Med. 2015;13:308. doi: 10.1186/s12967-015-0642-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-015-0642-6</ArticleId><ArticleId IdType="pmc">PMC4575470</ArticleId><ArticleId IdType="pubmed">26386558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Beetler D.J., Musigk N., Heidecker B., Lyle M.A., Cooper L.T., Jr., Bruno K.A. Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Front. Cardiovasc. Med. 2023;10:1129348. doi: 10.3389/fcvm.2023.1129348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1129348</ArticleId><ArticleId IdType="pmc">PMC10017519</ArticleId><ArticleId IdType="pubmed">36937911</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson D.P., Huber S.A., Moussawi M., Roberts B., Teuscher C., Watkins R., Arnold A.P., Klein S.L. Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis. Biol. Sex. Differ. 2011;2:8. doi: 10.1186/2042-6410-2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2042-6410-2-8</ArticleId><ArticleId IdType="pmc">PMC3162877</ArticleId><ArticleId IdType="pubmed">21806829</ArticleId></ArticleIdList></Reference><Reference><Citation>Case L.K., Toussaint L., Moussawi M., Roberts B., Saligrama N., Brossay L., Huber S.A., Teuscher C. Chromosome y regulates survival following murine coxsackievirus b3 infection. Genes Genomes Genet. 2012;2:115–121. doi: 10.1534/g3.111.001610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.111.001610</ArticleId><ArticleId IdType="pmc">PMC3276194</ArticleId><ArticleId IdType="pubmed">22384388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Zhang A., Du Y., Lu W., Wang J., Minze L.J., Cox T.C., Li X.C., Xing J., Zhang Z. TRIM18 is a critical regulator of viral myocarditis and organ inflammation. J. Biomed. Sci. 2022;29:55. doi: 10.1186/s12929-022-00840-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00840-z</ArticleId><ArticleId IdType="pmc">PMC9339186</ArticleId><ArticleId IdType="pubmed">35909127</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M., Mejia J.E., Chaumeil J., Guery J.C. Female predisposition to TLR7-driven autoimmunity: Gene dosage and the escape from X chromosome inactivation. Semin. Immunopathol. 2019;41:153–164. doi: 10.1007/s00281-018-0712-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0712-y</ArticleId><ArticleId IdType="pubmed">30276444</ArticleId></ArticleIdList></Reference><Reference><Citation>Umiker B.R., Andersson S., Fernandez L., Korgaokar P., Larbi A., Pilichowska M., Weinkauf C.C., Wortis H.H., Kearney J.F., Imanishi-Kari T. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. Eur. J. Immunol. 2014;44:1503–1516. doi: 10.1002/eji.201344283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201344283</ArticleId><ArticleId IdType="pmc">PMC4028042</ArticleId><ArticleId IdType="pubmed">24500834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>